Cargando…
Ethinylestradiol(30μg)-drospirenone and metformin: could this combination improve endothelial dysfunction in polycystic ovary syndrome?
BACKGROUND: We are hereby investigating for the first time the effect of the association ethinylestradiol(30μg)-drospirenone (3mg) (DRP/EE(30μg)) plus metformin and weight loss on endothelial status and C-reactive protein (hsCRP) levels in polycystic ovary syndrome (PCOS). METHODS: 25 young women wi...
Autores principales: | Ilie, Ioana Rada, Marian, Ioan, Mocan, Teodora, Ilie, Razvan, Mocan, Lucian, Duncea, Ileana, Pepene, Carmen Emanuela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413550/ https://www.ncbi.nlm.nih.gov/pubmed/22713099 http://dx.doi.org/10.1186/1472-6823-12-9 |
Ejemplares similares
-
Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
por: Mathur, Ruchi, et al.
Publicado: (2008) -
Influence of nanomaterials on stem cell differentiation: designing an appropriate nanobiointerface
por: Ilie, Ioana, et al.
Publicado: (2012) -
Nicotinamide-functionalized multiwalled carbon nanotubes increase insulin production in pancreatic beta cells via MIF pathway
por: Ilie, Ioana, et al.
Publicado: (2013) -
Pharmacokinetics of drospirenone and ethinylestradiol in Caucasian and Japanese women
por: Blode, Hartmut, et al.
Publicado: (2012) -
Surface plasmon resonance-induced photoactivation of gold nanoparticles as bactericidal agents against methicillin-resistant Staphylococcus aureus
por: Mocan, Lucian, et al.
Publicado: (2014)